Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...

The Metastatic Prostate Cancer clinical trial analysis report delivers important insights into ongoing research of 80+ ...

Thousands of men with prostate cancer could avoid the debilitating urinary and sexual side effects of surgery, thanks to a ...

A new treatment approved by the FDA in June is giving certain men with advanced prostate cancer another treatment option.

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...

A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate cancer cases without the need for a biopsy. Traditionally, a blood test can ...

Med Center Health is the first hospital in the region, and the seventh in the state, to offer a new treatment for patients with metastatic prostate cancer.

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and ...

Prostate cancer is the second leading cause of cancer deaths among men in the U.S. with more than 35,000 dying in 2025. It’s ...

Approximately 1 in 8 men will be diagnosed with prostate cancer during their lifetime often occurring later in life.

Please provide your email address to receive an email when new articles are posted on . Prostate cancer screening should begin at age 50, although Black men may need earlier screening. An expert ...